AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23058022
Drug: Hypertonic saline
RxNorm normalized name: ENTSOL Hypertonic Saline Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline (2.7% sodium chloride solution), administered twice-daily using a disposable 20 ml syringe for 4 weeks
Trial: 23058022
Drug: Normal saline,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline, administered twice-daily using a disposable 20 ml syringe for 4 weeks
Trial: 22738801
Drug: Sitagliptin 100
RxNorm normalized name: SITagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin 100 mg q.d.
Trial: 17300595
Drug: Glipizide 5
RxNorm normalized name: glipizide 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glipizide 5 mg/day (uptitrated to a maximum of 20 mg/day)
Trial: 11142674
Drug: PerioChip (chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PerioChip (chlorhexidine gluconate 2.5 mg)
Trial: 11189161
Drug: Predforte (10%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Predforte (10% prednisolone acetate) administered transnasally to the operative cavity
Trial: 7706104
Drug: Dextrose-saline solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextrose-saline solution containing 1 IU per ml of heparin
Trial: 7706104
Drug: Control solutions
RxNorm normalized name: Accu-Chek Comfort Curve Control Solutions
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control solutions (without heparin)
Trial: 30746976
Drug: Progressive Muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progressive Muscle Relaxation (PMR) with morphine 0.15 mg/kg daily in divided doses
Trial: 30746976
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with morphine 0.15 mg/kg daily in divided doses
Trial: 23905554
Drug: Intra-operative iv
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-operative iv administration of fluid boluses based on stroke volume measured by oesophageal Doppler (probe arm)
Trial: 21919372
Drug: Intravenous ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketamine (0.125 mg/kg) plus clonidine (0.5 microg/kg)
Trial: 21919372
Drug: Intravenous placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous placebo (sodium chloride 0.9%)
Trial: 19826560
Drug: Sildenafil (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (50 mg) as add-on to standard treatment for alcohol dependence
Trial: 19826560
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment for alcohol dependence without sildenafil
Trial: 15280526
Drug: Oxytocin infusion
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin infusion (20 mU/min)
Trial: 15280526
Drug: dDAVP (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dDAVP (2 micro g subcutaneously)
Trial: 11343530
Drug: Supportive-expressive group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive-expressive group therapy for 1 year
Trial: 31537527
Drug: Plerixafor (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plerixafor (400 μg/kg/day) infused intravenously for 4 consecutive weeks starting at day 35 of concurrent chemoradiation.
Trial: 31537527
Drug: Plerixafor (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plerixafor (400 μg/kg/day)
Trial: 29988514
Drug: rasagiline 1
RxNorm normalized name: rasagiline 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rasagiline 1 mg/day
Trial: 29748109
Drug: rasagiline 0.5
RxNorm normalized name: rasagiline 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rasagiline 0.5 mg/day
Trial: 21971943
Drug: GB-0998 (high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GB-0998 (high-dose intravenous immunoglobulin therapy)
Trial: 19204077
Drug: Exercise on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise on prescription intervention
Trial: 10812286
Drug: Naltrexone (0,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (0, 50, or 200 mg)
Trial: 1854464
Drug: DuP 753
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DuP 753 (2.5, 5, 10, 20, and 40 mg single dose)
Trial: 1854464
Drug: DuP 753
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DuP 753 (5, 10, 20, or 40 mg multiple dose, once daily for eight days)
Trial: 6396118
Drug: Bifonazole cream
RxNorm normalized name: bifonazole
DrugBank: Bifonazole (DB04794)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bifonazole cream vehicle
Trial: 28877011
Drug: Tezepelumab 70
RxNorm normalized name: Tezepelumab
DrugBank: Tezepelumab (DB15090)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tezepelumab 70 mg every 4 weeks
Trial: 28877011
Drug: Tezepelumab 280
RxNorm normalized name: Tezepelumab
DrugBank: Tezepelumab (DB15090)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tezepelumab 280 mg every 2 weeks
Trial: 16737850
Drug: Aspirin 325mg
RxNorm normalized name: ASPIRIN 325MG CAP
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 325mg
Trial: 9432316
Drug: Omeprazole plus
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole plus amoxicillin treatment regimen
Trial: 3811804
Drug: Fentanyl 0.002
RxNorm normalized name: fentanyl 0.002 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 0.002 mg/kg
Trial: 3811804
Drug: Fentanyl 0.004
RxNorm normalized name: fentanyl 0.004 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 0.004 mg/kg
Trial: 30075898
Drug: Dexmedetomidine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine infusion (0.5 µg/kg/h) during cardiopulmonary bypass
Trial: 30075898
Drug: Propofol continuous
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol continuous intravenous infusion (50 to 70 µg/kg/min)
Trial: 25411294
Drug: Non-enteric-coated (non-EC)
RxNorm normalized name: diclofenac
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Non-enteric-coated (non-EC) granules (500 mg)
Trial: 25411294
Drug: Non-enteric-coated (non-EC)
RxNorm normalized name: diclofenac
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Non-enteric-coated (non-EC) granules (1000 mg)
Trial: 25411294
Drug: Non-enteric-coated (non-EC)
RxNorm normalized name: diclofenac
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Non-enteric-coated (non-EC) granules (1500 mg)
Trial: 25411294
Drug: Enteric-coated (EC)
RxNorm normalized name: lipase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated (EC) granules (500 mg)
Trial: 25411294
Drug: Enteric-coated (EC)
RxNorm normalized name: lipase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated (EC) granules (1000 mg)
Trial: 25411294
Drug: Enteric-coated (EC)
RxNorm normalized name: lipase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated (EC) granules (1500 mg)
Trial: 25411294
Drug: FCA for
RxNorm normalized name: efgartigimod alfa-fcab Injection [Vyvgart]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FCA for 1000 mg dose compared to 500 mg
Trial: 25411294
Drug: FCA for
RxNorm normalized name: efgartigimod alfa-fcab Injection [Vyvgart]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FCA for 1500 mg dose compared to 500 mg
Trial: 22420492
Drug: DHEAS 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEAS 50 mg daily
Trial: 20978193
Drug: Serum 25-hydroxyvitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum 25-hydroxyvitamin D (25(OH)D) levels <25 nmol/L
Trial: 20978193
Drug: Serum 25-hydroxyvitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum 25-hydroxyvitamin D (25(OH)D) levels 25 to <37.5 nmol/L
Trial: 20978193
Drug: Serum 25-hydroxyvitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum 25-hydroxyvitamin D (25(OH)D) levels 37.5 to <50 nmol/L
Trial: 16037731
Drug: Gabapentin 800
RxNorm normalized name: gabapentin 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 800 mg (in two equally divided doses)
Trial: 12577433
Drug: Integrative traditional
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrative traditional Chinese and western medicine (TCM‐WM)
Trial: 12577433
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal medicine alone (TCM)
Trial: 12577433
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine alone (WM)
Trial: 8024076
Drug: Micronized halofantrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized halofantrine (8 mg/kg every 6 hr in three doses)
Trial: 8024076
Drug: Chloroquine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine (25 mg/kg for a 48-hr period) plus clindamycin (5 mg/kg every 12 hr in six doses)
Trial: 8024076
Drug: Chloroquine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine (25 mg/kg for a 48-hr period) plus doxycycline (2 mg/kg every 12 hr in six doses)
Trial: 2557685
Drug: Viscous CPRS
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Viscous CPRS containing carboxymethyl cellulose (CMC) gel for 8 hours
Trial: 2557685
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group soaked in saliva-like (SL) solution
Trial: 28328709
Drug: Low-fluence Q-switched
RxNorm normalized name: Chew Q
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fluence Q-switched 1,064-nm neodymium:yttrium-aluminum-garnet laser (QSNYL) weekly for 10 sessions on one cheek
Trial: 21384650
Drug: 1.25 mg
RxNorm normalized name: menthol 1.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 mg droperidol intravenously before operation
Trial: 15538041
Drug: Tamoxifen (TAM)
DrugBank: Tamoxifen (DB00675)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tamoxifen (TAM) 20 mg
Trial: 15538041
Drug: Toremifene (TOR)
DrugBank: Toremifene (DB00539)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Toremifene (TOR) 40 mg
Trial: 1617510
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (15 g/day MaxEPA, 4.5 g eicosapentaenoic and docosahexaenoic acids)
Trial: 29390862
Drug: Process incentives
RxNorm normalized name: allogeneic processed thymus tissue Drug Implant [Rethymic]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Process incentives (earned by attending primary care visits and/or receiving prescription medication refills)
Trial: 20210495
Drug: Sequential touching
RxNorm normalized name: benzethonium chloride Medicated Liquid Soap [Lysol Healthy Touch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential touching procedure for object categorization
Trial: 18603890
Drug: Risperidone 4‐6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone 4‐6 mg per day
Trial: 18603890
Drug: Haloperidol 10‐20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol 10‐20 mg per day
Trial: 10381297
Drug: High-dose garlic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose garlic powder dragees
Trial: 8709585
Drug: Investigator-observed flushing
RxNorm normalized name: T8 Keto Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Investigator-observed flushing after alcohol challenge (0.75 ml/kg alcohol)
Trial: 6359913
Drug: Combination ampicillin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination ampicillin, amikacin, and clindamycin (Group I)
Trial: 6359913
Drug: Combination doxycycline
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combination doxycycline and penicillin (Group II)
Trial: 10824881
Drug: Sitzmark capsule
RxNorm normalized name: Sitzmark Capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitzmark capsule administration
Trial: 10824881
Drug: Plasma concentration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma concentration of acetaminophen at 45 min after oral administration
Trial: 8637787
Drug: 3-week benzathine
RxNorm normalized name: etonogestrel
DrugBank: Etonogestrel (DB00294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-week benzathine penicillin G (BPG) program
Trial: 8637787
Drug: 4-week benzathine
RxNorm normalized name: milnacipran
DrugBank: Milnacipran (DB04896)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-week benzathine penicillin G (BPG) program
Trial: 1386223
Drug: Enoximone 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoximone 1.0 mg kg‐1 administered approximately 10 min before weaning from CPB
Trial: 29095180
Drug: Topical vapocoolant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical vapocoolant spray
Trial: 15645008
Drug: Alefacept (intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alefacept (intramuscular or intravenous administration)
Trial: 15645008
Drug: Alefacept (second
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alefacept (second course of therapy)
Trial: 11887654
Drug: Functionally loaded
RxNorm normalized name: stannous fluoride
DrugBank: Stannous fluoride (DB11092)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Functionally loaded implants (group 1)
Trial: 11887654
Drug: Unloaded one-stage
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unloaded one-stage control implants (group 2)
Trial: 11887654
Drug: Unloaded submerged
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unloaded submerged technique control implants (group 3)
Trial: 7906578
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg dimethindene
Trial: 7906578
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg dimethindene
Trial: 3276336
Drug: Nystatin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nystatin (1 ml, 100,000 units/ml) administered every 8 hours until 1 week after extubation
Trial: 22232848
Drug: Tablets containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablets containing soy isoflavones 60 mg (genistin 30 mg + daidzin 30 mg) + calcium and vitamin D3
Trial: 22232848
Drug: Tablets containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablets containing soy isoflavones 60 mg (genistin 30 mg + daidzin 30 mg) + calcium and vitamin D3 + 500 million vital spores of Lactobacillus sporogenes
Trial: 11076169
Drug: Empirically Supported
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empirically Supported Treatments
Trial: 24903556
Drug: Prophylactic bicyclol
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic bicyclol (75 mg, oral, daily)
Trial: 21422411
Drug: Control (chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (chemotherapy alone)
Trial: 20685497
Drug: Basal-bolus therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal-bolus therapy (BBT) with insulin glargine once daily plus mealtime insulin lispro TID
Trial: 20685497
Drug: LM75/25 (75%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LM75/25 (75% insulin lispro protamine suspension and 25% insulin lispro injection) BID
Trial: 20685497
Drug: LM50/50 (50%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LM50/50 (50% insulin lispro protamine suspension and 50% insulin lispro injection) TID
Trial: 17033111
Drug: Amoxicillin with
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin with clarithromycin and proton pump inhibitor (PPI)
Trial: 17033111
Drug: Amoxicillin with
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin with clarithromycin and PPI supplemented with Lacidofil
Trial: 10608746
Drug: pleconaril 200
RxNorm normalized name: pleconaril
DrugBank: Pleconaril (DB05105)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pleconaril 200 mg twice daily (initial dose of 400 mg)
Trial: 8859234
Drug: 4-mg intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-mg intravenous ondansetron
Trial: 7959523
Drug: Paroxetine (1x20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (1x20 mg/day)
Trial: 7959523
Drug: Doxepin (2x50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxepin (2x50 mg/day)
Trial: 3298420
Drug: Moclobemide (selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide (selective MAO-A-inhibitor)
Trial: 24082728
Drug: OHA +
RxNorm normalized name: 4-OHAD
DrugBank: Formestane (DB08905)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OHA + 50 mg elemental zinc as zinc sulphate supplementation for 12 weeks
Trial: 17164695
Drug: Single-dose activated
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose activated charcoal (SDAC)
Trial: 17164695
Drug: Multiple-dose activated
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-dose activated charcoal (MDAC)
Trial: 10922195
Drug: Topical anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anesthesia (2% lidocaine, minimum of 5 doses, approximately 40 microL per dose)
Trial: 10922195
Drug: Retrobulbar anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Retrobulbar anesthesia (3.5-5.5 mL of a combination of 0.75% bupivacaine hydrochloride, 2% lidocaine, and hyaluronidase)
Trial: 8786727
Drug: GHRH (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHRH (1 microgram/kg body weight intravenous bolus)
Trial: 8786727
Drug: L-arginine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (50 g in 50 mL normal saline over 30 minutes)
Trial: 2199394
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose polyoestradiol phosphate (160 mg i.m. monthly)
Trial: 30929591
Drug: Aerobic exercise
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerobic exercise treatment group (n = 21)
Trial: 24642450
Drug: Weekly estimated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly estimated intake of isoflavones
Trial: 19520448
Drug: 8 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 Gy single-dose RT
Trial: 16616994
Drug: Hydromorphone (HYD)
DrugBank: Hydromorphone (DB00327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydromorphone (HYD) doses of 12 mg and 24 mg IM
Trial: 16616994
Drug: Pre-session supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-session supplements of HYD (12 mg or 24 mg)
Trial: 16616994
Drug: Different FR/unit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different FR/unit dose combinations
Trial: 11323364
Drug: 0.25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/kg epidural S(+)‐ketamine
Trial: 11323364
Drug: Ropivacaine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine (10 mg/mL, 10‐20 mL)
Trial: 28343225
Drug: Vadadustat (240,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vadadustat (240, 370, 500, or 630 mg once-daily for 6 weeks)
Trial: 26304864
Drug: Deferoxamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferoxamine infusion
Trial: 8706772
Drug: Buffered sublingual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buffered sublingual captopril (12.5 mg)
Trial: 8706772
Drug: Peroral captopril
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Peroral captopril (administered with 100 ml of water)
Trial: 6143667
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 mg b.i.d.
Trial: 29217088
Drug: Induction cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Induction cisplatin (80 mg/m2) and docetaxel (75 mg/m2) for 3 cycles followed by surgery and adjuvant erlotinib for 12 months
Trial: 26763489
Drug: Ivabradine 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivabradine 2.5 mg BID
Trial: 26763489
Drug: Ivabradine 5
RxNorm normalized name: ivabradine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivabradine 5 mg BID
Trial: 15205987
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg diclofenac daily
Trial: 15205987
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg diclofenac daily
Trial: 11449205
Drug: Budesonide (BUD)
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide (BUD) 400 microg once daily
Trial: 11449205
Drug: Budesonide (BUD)
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide (BUD) 200 microg once daily
Trial: 11449205
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate (MF) 100 microg once daily